Lv21
160 积分 2022-02-21 加入
TYK2: an emerging therapeutic target in rheumatic disease
2小时前
待确认
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
19天前
已完结
Inhibitors and PROTACs of CDK2: challenges and opportunities
26天前
已完结
HCV RdRp, sofosbuvir and beyond
2个月前
已完结
Structure-Based Drug Design of RdRp Inhibitors against SARS-CoV-2
2个月前
已完结
Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions
3个月前
已完结
Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs
3个月前
已完结
Discovery of gem-Dimethyl-hydroxymethylpyridine Derivatives as Potent Non-nucleoside RSV Polymerase Inhibitors
3个月前
已完结
The pipeline and market for psoriasis drugs
3个月前
已完结
Small-molecule anti-COVID-19 drugs and a focus on China’s homegrown mindeudesivir (VV116)
4个月前
已完结
皖公网安备34019202002308
